Our results suggested that the polymer-drug conjugate nanoparticles could effectively alleviate the pathology of stroke, reduce infarct volume, and enhance neurogenesis, through inhibiting HMGB1 translocation and switching microglia M1 or M2 phenotype. Here, HMGB1 is linked to Stroke.